Product Program year 2025 Source: CMS Open Payments

Torpenz

Drug Neurology

NDC 0245-0825-30

Open in the dashboard

General payments

$20,976

351 payments

Research payments

$0

0 payments

Through program year 2025, $20,976 in general payments and $0 in research payments were reported against Torpenz (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $6,135 222
2024 General $14,841 129

Breakdown

Who paid General payments · program years 2024–2025
  1. Upsher-Smith Laboratories LLC $20,976 351 payments
Top recipients General payments · program year 2025
  1. Holly Keeley Neurology with Special Qualifications in Child Neurology · Austin, TX $122 2% · 3 payments
  2. Daniel Gustkey Epilepsy · Austin, TX $122 2% · 3 payments
  3. Sarah Weatherspoon Epilepsy · Memphis, TN $103 2% · 4 payments
  4. Lai Brooks Nurse Practitioner · Memphis, TN $103 2% · 4 payments
  5. Brittani Ireland Nurse Practitioner, Pediatrics · Memphis, TN $103 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $2,103 36% · 63 practitioners
  2. Neurology Psychiatry & Neurology $770 13% · 20 practitioners
  3. Nurse Practitioner, Pediatrics Nurse Practitioner $726 12% · 19 practitioners
  4. Epilepsy Psychiatry & Neurology $536 9% · 8 practitioners
  5. Nurse Practitioner $469 8% · 12 practitioners

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $1,304 21% · 28 recipients
  2. Tennessee $1,283 21% · 29 recipients
  3. Louisiana $697 11% · 18 recipients
  4. Alabama $676 11% · 20 recipients
  5. Michigan $541 9% · 19 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

351 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record